BMI View: Domestic pharmaceutical companies in Argentina are more competitive than many other Latin American drugmakers. Unlike neighbouring country Brazil, which can lure multinationals to supply advanced technologies in exchange for a secure market share in its attractive drug market, innovative developments in Argentina are mostly self-initiated or from collaborations with other developing countries. The freeze or downscaling of local operations from multinationals has also indirectly provided more scope for expansion to Argentinean drugmakers. In addition, local manufacturers have expanded in other emerging market to offset the negative impact of limited growth in their domestic markets and increasing competition from …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131537.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/argentina-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.
No comments:
Post a Comment